<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04409119</url>
  </required_header>
  <id_info>
    <org_study_id>HIS alternative 2</org_study_id>
    <nct_id>NCT04409119</nct_id>
  </id_info>
  <brief_title>Direct HIS/LBB Pacing as an Alternative to Biventricular Pacing in Patients With HFrEF and a Typical LBBB.</brief_title>
  <acronym>HIS-alt_2</acronym>
  <official_title>Direct HIS/LBB Pacing as an Alternative to Biventricular Pacing in Patients With Symptomatic Heart Failure Despite Optimal Medical Treatment and an ECG With a Typical Left Bundle Branch Block Pattern.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will investigate the feasibility of using direct HIS pacing or left bundle branch&#xD;
      pacing (LBB pacing) as an alternative to biventricular pacing in patients with symptomatic&#xD;
      heart failure and an ECG with a typical left bundle branch block pattern.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Biventricular pacing has for more than a decade been standard of care for patients with&#xD;
      HFrEF, LVEF &lt; 35%, NYHA II-IV despite optimal medical treatment and an ECG with left bundle&#xD;
      branch block (LBBB). However, it is not always ideal because of several drawbacks such as&#xD;
      phrenic nerve capture, inability to reach late activated areas and many more. Direct HIS&#xD;
      pacing can in many cases capture the left bundle and provide normal electrical activation of&#xD;
      the left ventricle but sometimes with high pacing thresholds. Recently direct left bundle&#xD;
      branch pacing has shown promise with synchronous activation of the left ventricle at low&#xD;
      pacing thresholds.&#xD;
&#xD;
      In the present study we randomize 125 patients in one center to either conventional CRT (45&#xD;
      patients) or HIS/LBB pacing (80 patients). In the HIS/LBB arm, direct HIS-pacing is attempted&#xD;
      first but if its not possible or the pacing threshold for capturing the left bundle branch is&#xD;
      &gt; 2.5 V at 1 ms we switch to placing a LBB-lead.&#xD;
&#xD;
      Power calculation for non-inferiority: With the 50 patients in the first His Alternative&#xD;
      study (25 Biv-CRT og 25 His-CRT) we observed a fall in systolic volumes of 34% and 46% with a&#xD;
      standard deviation of 13-16%. Using these numbers it would take at least 108 patients to be&#xD;
      90% sure that the lower limit of a one-sided 97.5% confidence interval (equal to a 95%&#xD;
      two-sided confidence interval) would be over the non-inferiority limit of -10%.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Anticipated">January 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>The patient and the staff performing and evaluating echocardiography and hall-walk tests are blinded to the treatment arm</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Left ventricular end-systolic volume</measure>
    <time_frame>6 months</time_frame>
    <description>Echocardiographic response after 6 months defined as decrease in left ventricular systolic volume of ≥ 15% of baseline</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Success rate of implanting a HIS-bundle lead with capture of the left bundle branch or a LBB-lead with narrowing of QRS</measure>
    <time_frame>6 months</time_frame>
    <description>The success rate of implanting a pacing lead to the HIS-bundle with capture of the left bundle at a threshold &lt; 2.5 V at 1 ms or implantation of a LBB lead with narrowing of the QRS duration and maintaining this effect at 6 month follow-up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in LVEF and left ventricular chamber dimensions</measure>
    <time_frame>6 months</time_frame>
    <description>Echocardiographic response assessed by chamber dimensions and LVEF on a continuous scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in 6-min hall-walk test</measure>
    <time_frame>6 months</time_frame>
    <description>Functional response after 6 months defined as an increase in 6-min walking distance of ≥ 20% of the initial value</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in NYHA class</measure>
    <time_frame>6 months</time_frame>
    <description>Symptomatic response after 6 months defined as a fall in NYHA class of ≥ 1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Minnesota Living with Heart Failure score</measure>
    <time_frame>6 months</time_frame>
    <description>Change in well-being after 6 months defined as a decrease in Minnesota Living With Heart Failure score of ≥ 15% of baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Shortening of QRS duration</measure>
    <time_frame>6 months</time_frame>
    <description>Shortening the duration of the QRS complex defined as the widest paced QRS complex rated at 12-lead ECG after 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in NT-pro BNP value</measure>
    <time_frame>6 months</time_frame>
    <description>Change in NT-pro BNP value</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>6 months</time_frame>
    <description>Device-related complications (periprocedural: electrode reoperation, pneumothorax, hemothorax, pericardial bleeding/tamponade and later (after 30 days post implantation): LV/HIS electrode reoperation, change of device due to battery depletion and infection requiring extraction).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">125</enrollment>
  <condition>Heart Failure</condition>
  <condition>Left Bundle-Branch Block</condition>
  <arm_group>
    <arm_group_label>HIS/LBB pacing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this arm a right ventricular (RV) lead or implantable cardioverter defibrillator (ICD) lead is placed first and then implantation of a HIS-pacing lead is attempted. If it is not possible to find and pace HIS, to correct the LBBB or the threshold for correcting the LBBB is &gt; 2.5 V at 1 ms, implantation of a LBB-pacing lead is attempted instead. If that is not possible either, a left ventricular (LV) lead is implanted.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LV pacing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In this arm an RV-lead or ICD-lead is placed first and then implantation of a LV-pacing lead is attempted. If this is not possible due to anatomical difficulties (no coronary sinus (CS) access, no available branches other than v cordis anterior or v cordis media) or electrical difficulties (no capture below 4 V at 1.0 msec or phrenic nerve stimulation &lt; 2x pacing threshold), implantation of a HIS-pacing lead is attempted instead. If that is not possible or the threshold for correcting the LBBB is &gt; 2.5 V at 1 ms, implantation of a LBB-pacing lead is attempted instead.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HIS/LBB pacing</intervention_name>
    <description>3830 lead to HIS or LBB</description>
    <arm_group_label>HIS/LBB pacing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LV pacing</intervention_name>
    <description>LV lead in a CS branch</description>
    <arm_group_label>LV pacing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients over 18 years of age, ischemic or non-ischemic cardiomyopathy with LVEF ≤ 35%&#xD;
             assessed by echocardiography, NYHA class II-IV heart failure symptoms despite optimal&#xD;
             medical treatment and&#xD;
&#xD;
               -  Either planned new implantation of a biventricular pacing system (CRT-P or&#xD;
                  CRT-D), where the ECG is with sinus rhythm and a typical left bundle branch block&#xD;
                  (see definition below)&#xD;
&#xD;
               -  Or planned upgrade of an existing pacemaker or ICD to a biventricular pacing&#xD;
                  system (CRT-P or CRT-D), where the ECG is with sinus rhythm and a typical left&#xD;
                  bundle branch block or there has been&gt; 90% right ventricular pacing from an&#xD;
                  existing pacemaker for at least 2 months prior to enrollment&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Typical left bundle branch block:&#xD;
&#xD;
        QRS width &gt; 130 msec for women and &gt; 140 msec for men QS or rS pattern in leads V1 and V2,&#xD;
        and mid-QRS plateau phase with or without extras in at least 2 of leads V1, V2, V5, V6, I,&#xD;
        and aVL&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Existing biventricular pacing system&#xD;
&#xD;
          -  Permanent atrial fibrillation&#xD;
&#xD;
          -  Severe renal failure with eGFR &lt; 30 ml/min&#xD;
&#xD;
          -  AMI or CABG within the last three months&#xD;
&#xD;
          -  The patient does not want to participate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Vinther, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Berit Th Philbert, MD PhD</last_name>
    <phone>+4535451410</phone>
    <email>berit.thornvig.philbert@regionh.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Niels Risum, MD PhD</last_name>
    <phone>+4535456995</phone>
    <email>niels.risum.01@regionh.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <state>Hovedstaden</state>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Vinther, MD PhD</last_name>
      <phone>+4535456994</phone>
      <email>michael.vinther@regionh.dk</email>
    </contact>
    <contact_backup>
      <last_name>Anne-Sofie Ellekilde, RN</last_name>
      <phone>+4535450923</phone>
      <email>Anne-sofie.ellekilde@regionh.dk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>May 26, 2020</study_first_submitted>
  <study_first_submitted_qc>May 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2020</study_first_posted>
  <last_update_submitted>August 2, 2021</last_update_submitted>
  <last_update_submitted_qc>August 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Michael Vinther</investigator_full_name>
    <investigator_title>Chief Physician Electrophysiology</investigator_title>
  </responsible_party>
  <keyword>left bundle branch block</keyword>
  <keyword>HIS-pacing</keyword>
  <keyword>LBB-pacing</keyword>
  <keyword>left bundle branch pacing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Bundle-Branch Block</mesh_term>
    <mesh_term>Heart Block</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

